Cepinskas Gediminas, Katada Kazuhiro, Bihari Aurelia, Potter Richard F
Centre for Critical Illness Research, Lawson Health Research Institute, London, Ontario, N6A 4G4, Canada.
Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G184-91. doi: 10.1152/ajpgi.00348.2007. Epub 2007 Nov 8.
Recent studies suggest that exogenously administered CO is beneficial for the resolution of acute inflammation. In this study, we assessed the role of CO liberated from a systemically administered tricarbonyldichlororuthenium-(II)-dimer (CORM-2) on modulation of liver inflammation during sepsis. Polymicrobial sepsis in mice was induced by cecal ligation and perforation (CLP). CORM-2 (8 mg/kg iv) was administered immediately after CLP induction, and neutrophil [polymorphonuclear leukocyte (PMN)] tissue accumulation, activation of transcription factor, NF-kappaB, and changes in adhesion molecule ICAM-1 expression (inflammation-relevant markers) were assessed in murine liver 24 h later. In addition, the effects and potential mechanisms of CORM-2-released CO in modulation of vascular endothelial cell proinflammatory responses were assessed in vitro. To this end, human umbilical vein endothelial cells (HUVEC) were stimulated with LPS (1 microg/ml) in the presence or absence of CORM-2 (10-100 microM) and production of intracellular reactive oxygen species (ROS), (DHR123 oxidation) and NO (DAF-FM nitrosation) and subsequent activation of NF-kappaB were assessed 4 h later. In parallel, expression of ICAM-1 and inducible NO synthase (iNOS) proteins along with PMN adhesion to LPS-challenged HUVEC were also assessed. Induction of CLP resulted in increased PMN accumulation, ICAM-1 expression, and activation of NF-kappaB in the liver of septic mice. These effects were significantly attenuated by systemic administration of CORM-2. In in vitro experiments, CORM-2-released CO attenuated LPS-induced production of ROS and NO, activation of NF-kappaB, increase in ICAM-1 and iNOS protein expression and PMN adhesion to LPS-stimulated HUVEC. Taken together, these findings indicate that CO released from systemically administered CORM-2 provides anti-inflammatory effects by interfering with NF-kappaB activation and subsequent downregulation of proadhesive vascular endothelial cell phenotype in the liver of septic mice.
近期研究表明,外源性给予一氧化碳(CO)有利于急性炎症的消退。在本研究中,我们评估了全身给予二氯二羰基钌(II)二聚体(CORM-2)释放的CO在脓毒症期间对肝脏炎症调节的作用。通过盲肠结扎和穿孔(CLP)诱导小鼠发生多微生物脓毒症。在CLP诱导后立即静脉注射CORM-2(8mg/kg),24小时后在小鼠肝脏中评估中性粒细胞[多形核白细胞(PMN)]组织积聚、转录因子NF-κB的激活以及黏附分子ICAM-1表达的变化(炎症相关标志物)。此外,在体外评估了CORM-2释放的CO调节血管内皮细胞促炎反应的作用及潜在机制。为此,在存在或不存在CORM-2(10 - 100μM)的情况下,用脂多糖(LPS,1μg/ml)刺激人脐静脉内皮细胞(HUVEC),4小时后评估细胞内活性氧(ROS)的产生(DHR123氧化)、一氧化氮(NO)的产生(DAF-FM亚硝化)以及随后NF-κB的激活。同时,还评估了ICAM-1和诱导型一氧化氮合酶(iNOS)蛋白的表达以及PMN对LPS刺激的HUVEC的黏附。CLP诱导导致脓毒症小鼠肝脏中PMN积聚增加、ICAM-1表达增加以及NF-κB激活。全身给予CORM-2可显著减轻这些作用。在体外实验中,CORM-2释放的CO减弱了LPS诱导的ROS和NO产生、NF-κB激活、ICAM-1和iNOS蛋白表达增加以及PMN对LPS刺激的HUVEC的黏附。综上所述,这些发现表明全身给予CORM-2释放的CO通过干扰NF-κB激活以及随后下调脓毒症小鼠肝脏中促黏附血管内皮细胞表型发挥抗炎作用。